These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16164618)

  • 1. Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.
    Rao M; Pereira BJ
    Kidney Int; 2005 Oct; 68(4):1432-8. PubMed ID: 16164618
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Pediatric Chronic Kidney Disease.
    Kaspar CD; Bholah R; Bunchman TE
    Blood Purif; 2016; 41(1-3):211-7. PubMed ID: 26766175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin-induced treatment costs in patients suffering from renal anemia - a comparison between biosimilar and originator drugs.
    Hörbrand F; Rottenkolber D; Fischaleck J; Hasford J
    Gesundheitswesen; 2014 Nov; 76(11):e79-84. PubMed ID: 24493578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
    Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
    Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in the elderly-clinical findings and impact on health.
    Balducci L; Ershler WB; Krantz S
    Crit Rev Oncol Hematol; 2006 May; 58(2):156-65. PubMed ID: 16387511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?
    Orth SR; Hallan SI
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):226-36. PubMed ID: 18003763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of progression of CKD.
    Yang M; Fox CH; Vassalotti J; Choi M
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):400-5. PubMed ID: 22098657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery calcification and cardiovascular mortality in predialysis patients.
    Russo D; Morrone L; Russo L
    Kidney Int; 2011 Jan; 79(2):258; author reply 258. PubMed ID: 21191391
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing the burden of chronic kidney disease.
    Thorp ML; Eastman L; Smith DH; Johnson ES
    Dis Manag; 2006 Apr; 9(2):115-21. PubMed ID: 16620197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients.
    Hassan SB; El-demery AB; Ahmed AI; Abukhalil RE
    Arab J Nephrol Transplant; 2012 Jan; 5(1):27-32. PubMed ID: 22283863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of risk grading system using albuminuria for predicting cardiovascular events and all-cause death in chronic kidney disease: a population-based prospective cohort study in Japan.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Omama S; Onoda T; Nakamura M
    Int J Cardiol; 2014 Aug; 175(3):576-7. PubMed ID: 24874904
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.
    Tsai YC; Chiu YW; Tsai JC; Kuo HT; Hung CC; Hwang SJ; Chen TH; Kuo MC; Chen HC
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):39-46. PubMed ID: 25512646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):397-405. PubMed ID: 16198279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wellpoint/Anthem approach to chronic kidney disease.
    Howard RL
    Nephrol News Issues; 2005 Nov; 19(12):49-51, 88. PubMed ID: 16315545
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the management of chronic kidney disease.
    Rivera JA; O'Hare AM; Harper GM
    Am Fam Physician; 2012 Oct; 86(8):749-54. PubMed ID: 23062158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
    Iimori S; Naito S; Noda Y; Nishida H; Kihira H; Yui N; Okado T; Sasaki S; Uchida S; Rai T
    Nephrology (Carlton); 2015 Sep; 20(9):601-8. PubMed ID: 25917812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.
    Schjelderup P; Dahle DO; Holdaas H; Mjøen G; Nordby G; Abedini S; Jardine A; Fellström B; Svensson M
    Clin Transplant; 2013; 27(6):E636-43. PubMed ID: 23991916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk estimated in renal transplant recipients with the Framingham score.
    de Pádua Netto MV; Bonfim TC; Costa EN; de Lima HV; Netto LC
    Transplant Proc; 2012 Oct; 44(8):2337-40. PubMed ID: 23026587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.